https://ogma.newcastle.edu.au/vital/access/ /manager/Index en-au 5 Clinical relevance of brown snake (Pseudonaja spp) factor V escaping hemostatic regulation (letter) https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:7335 Sat 24 Mar 2018 08:35:13 AEDT ]]> Impact of early dose intensity on cytogenetic and molecular responses in chronic- phase CML patients receiving 600 mg/day of imatinib as initial therapy https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:5045 Sat 24 Mar 2018 07:45:38 AEDT ]]> All-trans-retinoic acid, idarubicin, and IV arsenic trioxide as initial therapy in acute promyelocytic leukemia (APML4) https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:25283 Sat 24 Mar 2018 07:38:13 AEDT ]]> Sorafenib plus intensive chemotherapy in newly diagnosed FLT3-ITD AML: a randomized, placebo-controlled study by the ALLG https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:54830 Fri 15 Mar 2024 11:53:47 AEDT ]]>